Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants. IICLARK, W. G; LIPTON, J. M.Neuroscience and biobehavioral reviews. 1986, Vol 10, Num 2, pp 153-220, issn 0149-7634Article

Discussant presentation : serotonin partial agonists in the treatment of depressionDIMITRIOU, E.The Journal of clinical psychiatry. 1990, Vol 51, Num SEP, pp 65-66, issn 0160-6689, 2 p., SupplConference Paper

Dominant social status facilitates the behavioral effects of serotonergic agonistsRALEIGH, M. J; BRAMMER, G. L; MCGUIRE, M. T et al.Brain research. 1985, Vol 348, Num 2, pp 274-282, issn 0006-8993Article

Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist?GERBER, R; BARBAZ, B. J; MARTIN, L. L et al.Neuroscience letters. 1985, Vol 60, Num 2, pp 207-213, issn 0304-3940Article

Dissociation constants of serotonin agonists in the canine basilar artery correlate to K_i values at the 5-HT_1A binding siteTAYLOR, E. W; PIPER DUCKLES, S; NELSON, D. L et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 236, Num 1, pp 118-125, issn 0022-3565Article

Influence of p-chloroamphetamine and methysergide on the escape deficits provoked by inescapable shockHAMILTON, M. E; ZACHARKO, R. M; ANISMAN, H et al.Psychopharmacologia. 1986, Vol 90, Num 2, pp 203-206, issn 0033-3158Article

Recent advances in central 5-hydroxytryptamine receptor agonists and antagonistsARVIDSSON, L.-E; HACKSELL, U; GLENNON, R. A et al.Progress in drug research. 1986, Vol 30, pp 365-471, issn 0071-786XArticle

Apneusis responding to buspirone in multiple sclerosisO'SULLIVAN, R. J; BROWN, I. G; PENDER, M. P et al.Multiple sclerosis. 2008, Vol 14, Num 5, pp 705-707, issn 1352-4585, 3 p.Article

Drug reactions : sumatriptan and chest painHILLIS, W. S; MACINTYRE, P. D.Lancet (British edition). 1993, Vol 341, Num 8860, pp 1564-1565, issn 0140-6736Article

II sumatriptan nella terapia dell'emicrania = Sumatriptan and migraineAMETRANO, P; ABU HWEIJ, F.Archivio di medicina interna (Parma). 1993, Vol 45, Num 2, pp 73-77, issn 0004-010XArticle

Changes in attitude toward food by obese patients treated with placebo and serotoninergic agentsBAGIELLA, E; CAIRELLA, M; DEL BEN, M et al.Current therapeutic research. 1991, Vol 50, Num 2, pp 205-210, issn 0011-393XArticle

Theoretical determination of the putative receptor-bound conformations of 5-HT₂ receptor agonistsHÖLTJE, H.-D; BRIEM, H.Quantitative structure-activity relationships. 1991, Vol 10, Num 3, pp 193-197, issn 0931-8771Article

Neurochemistry and neurophysiology of buspirone and gepirone : interactions at presynaptic and postsynaptic 5-HT_1A receptorsYOCCA, F. D.Journal of clinical psychopharmacology. 1990, Vol 10, Num 3, pp 6S-12S, issn 0271-0749, supplConference Paper

Kinetic definition of agonist efficacy at a 5-hydroxytryptamine (5-HT₂) receptor in the isolated rabbit aortaCORY, R. N; OSMAN, R; MAAYANI, S et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 236, Num 1, pp 48-54, issn 0022-3565Article

Discriminative stimulus properties of the serotonin agonist MK 212CUNNINGHAM, K. A; CALLAHAN, P. M; APPEL, J. B et al.Psychopharmacologia. 1986, Vol 90, Num 2, pp 193-197, issn 0033-3158Article

The Counteraction of Opioid-lnduced Ventilatory Depression by the Serotonin lA-Agonist 8-OH-DPAT Does Not Antagonize Antinociception in Rats In Situ and In VivoGUENTHER, Ulf; MANZKE, Till; WRIGGE, Hermann et al.Anesthesia and analgesia. 2009, Vol 108, Num 4, pp 1169-1176, issn 0003-2999, 8 p.Article

The longitudinal effects of fenfluramine-phentermine useFLEMING, Richard M; BOYD, Larry B.Angiology. 2007, Vol 58, Num 3, pp 353-359, issn 0003-3197, 7 p.Article

A validated chiral CE method for Frovatriptan, using cyclodextrin as chiral selectorKHAN, Muzaffar; VISWANATHAN, Balaji; SREENIVAS RAO, D et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1447-1452, issn 0731-7085, 6 p.Article

Sumatriptan does not affect vasopressin secretion in humansBARRECA, T; FRANCESCHINI, R; CATALDI, A et al.Clinical neuropharmacology. 1993, Vol 16, Num 6, pp 555-558, issn 0362-5664Article

Studies on the enhancement of 5-hydroxytryptamine-mediated behaviour by chlormethiazole and phenytoinGREEN, A. R; DE SOUZA, R. J; CROSS, A. J et al.Journal of psychopharmacology (Oxford). 1992, Vol 6, Num 3, pp 370-375, issn 0269-8811Article

A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteersLAWLOR, B. A; NEWHOUSE, P. A; BALKIN, T. J et al.Biological psychiatry (1969). 1991, Vol 29, Num 3, pp 281-286, issn 0006-3223, 6 p.Article

Novel enteric 5-HT₄ receptors and gastrointestinal prokinetic actionTONINI, M; RIZZI, C. A; MANZO, L et al.Pharmacological research. 1991, Vol 24, Num 1, pp 5-14, issn 1043-6618Article

Stereospecific inhibition of non-opioid defeat analgesia in male mice by MDL 72832, a selective 5-HT_1A receptor agonistRODGERS, R. J; SHEPHERD, J. K.European journal of pharmacology. 1990, Vol 182, Num 3, pp 581-585, issn 0014-2999, 5 p.Article

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazineBREWERTON, T. D; MURPHY, D. L; MUELLER, E. A et al.Clinical pharmacology and therapeutics. 1988, Vol 43, Num 6, pp 605-609, issn 0009-9236Article

Serotonin₂ agonist administration down-regulates rat brain serotonin₂ receptorsBUCKHOLTZ, N. S; ZHOU, D; FREEDMAN, D. X et al.Life sciences (1973). 1988, Vol 42, Num 24, pp 2439-2445, issn 0024-3205Article